Abstract
Introduction: Healthcare-associated infections (HCAIs) contribute to significant morbidity, mortality and economic costs. There are many different ways of preventing hospital infections. An effective infection control programme (ICP) should be a cost-effective medical intervention. Hence, the current study was undertaken to determine the cost-effectiveness of the ICP for the years 2015–2016 and 2014–2015 in comparison to 2013–2014. Methodology: This study was conducted in a 400-bedded super speciality hospital. The infection control budget for the years 2013–2014, 2014–2015 and 2015–2016 was calculated. Incremental cost-effectiveness ratio (ICER) was calculated as the difference in cost between two interventions divided by the difference in health benefit obtained. Results: The total expense incurred on the ICP in the year 2013–2014 was Rs. 1,640,162. In the years 2014–2015 and 2015–2016, the ICP was upgraded with an incremental budget of Rs. 816,208 and Rs. 1,025,730, respectively. There was a significant reduction in HCAI rates in the years 2014–2015 and 2015–2016. The ICER for the years 2014–2015 and 2015–2016 was 68,017.33 and 60,337.05, respectively. Based on the analysis, the ICP for the year 2015–2016 was more cost-effective. Conclusion: The incremental budgeting for the new ICP for the year 2015–2016 proved to be a more efficient and cost-beneficial intervention for infection control.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
